Metropolis Healthcare Reports Strong Q2 FY27 With PAT Surging 43% YoY
Metropolis Healthcare Ltd · Press Release · 04 Nov 2026, 1:13 am
Metropolis Healthcare Reports Strong Q2 FY27 With PAT Surging 43% YoY Metropolis Healthcare reported robust Q2 FY27 results, with revenue rising 15.8% YoY to ₹496.8 crore and PAT surging 42.7% YoY to ₹75.5 crore. EBITDA grew 23.9% YoY to ₹134.9 crore, with EBITDA margins expanding 180 bps to 27.2%. Volume growth remained healthy, with patient volumes up 10% YoY to 4.1 million and test volumes rising 11% YoY to 8.7 million. TruHealth and Specialty revenues each grew 20% YoY, while B2C revenue increased 17% YoY. The Board declared an interim dividend of ₹1 per share.
Original exchange filing (PDF)
More announcements from Metropolis Healthcare Ltd
- Transcript of Q2 and H1 FY27 earnings conference call held on November 04, 2026 · 10 Nov 2026
- Schedule of Analyst / Institutional Investor Meeting · 05 Nov 2026
- Link of the audio recording of the earnings conference call held on November 04, 2026 · 04 Nov 2026
- Investor Presentation for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Board approves Interim Dividend · 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Metropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 04 Nov 2026
- Outcome of Board Meeting · 04 Nov 2026
